Abstract
In this chapter, some of the legal challenges of research biobanking are discussed and illustrated by examples of possible analogies as well some comparative notes on the regulatory strategies adopted in the Nordic countries. Human biological material is compared with biologicalwaste, raw materials, human beings, personal or nonidentifiable health data, and different kinds of public resources. It is concluded that the complex nature of human biobanks would seem to defy any attempt at a simplified regulatory analogy. Even so, it is clear that the application of more sophisticated analogical reasoning will still be valuable in the regulatory process and that policy makers must try to identify an appropriate combination of diverse approaches. While the international nature of biomedical research provides a strong incentive for more harmonised rules, the regulatory process is here further complicated by the plurality of religious, cultural, social and legal traditions, as well as issues of regulatory competence. Nevertheless, some degree of regional or even international consensus could certainly be reached with regard to less controversial areas and issues, and this potential must be further explored. The regulation of research biobanking should be perceived as an ongoing step-by-step process, rather than a problem that will soon be solved once and for all. In the short-term perspective especially, it must be expected that legal restrictions and administrative inconveniences may cause additional costs and delay or even prevent promising research. The long-term aim must be to serve the best interests of the public, by a careful balancing of the freedom of research against other fundamental rights and values.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Annas, G.J. (1999) Waste and Longing – The Legal Status of Placental-Blood Banking, New England Journal of Medicine 340: 1521–1524.
Annas, G.J. (1988) Whose Waste Is It Anyway? The Case of John Moore, The Hastings Center Report, Vol. 18, No. 5, pp. 37–39.
Arnardottir, O.M. et al. (1999) The Icelandic Health Sector Data Base, European Journal of Health Law 6: 307–362.
Berg, K. (1983) Ethical Problems Arising from Research Progress in Medical Genetics. In: Berg, K. & Tranøy, K.E (eds.) Research Ethics, Alan R. Liss, New York, pp. 261–275.
Beyleveld, D. & Brownsword, R. (2001) Human Dignity in Bioethics and Biolaw, Oxford Univeristy Press, Oxford.
Burrell, R. (2006) Assisted Reproduction in the Nordic Countries – A Comparative Study of Policies and Regulation, TemaNord 2006:505, Nordic Committee on Bioethics, www.norden.org/pub/sk/showpub.asp?pubnr=2006:505.
Cambon-Thomsen, A. et al. (2007) Trends in Ethical and Legal Frameworks for the Use of Human Biobanks, Eur Respir J 30: 373–382.
Elger, B.S. & Caplan, A.L. (2006) Consent and Anonymization in Research Involving Biobanks: Differing Terms and Norms Present Serious Barriers to an International Framework. EMBO Rep 7(7): 661–666.
Eriksson, S. (2003) Mapping the Debate on Informed Consent. In: Hansson, M. & Levin, M. (eds.) Biobanks as Resources for Health, Research Program Ethics in Biomedicine, Uppsala University, Uppsala, pp. 165–196.
Frykman, H. & Mörth, U. (2004) Soft Law and Three Notions of Democracy: The Case of the EU. In: Mörth, U. (ed.) Soft Law in Governance and Regulation: An Interdisciplinary Analysis, E. Elgar Publisher, Northampton, MA, pp. 155–179.
Gadd, E. (2005) The Global Significance of the Convention on Human Rights and Biomedicine. In: Gevers, J.K.M., Hondius, E.H. & Hubben, J.H. (eds.) Health Law, Human Rights and the Biomedicine Convention, Martinus Nijhoff Publishers, Boston, MA.
Gertz, R. (2004) Is it ‘Me’ or ‘We’? Genetic Relations and the Meaning of ‘Personal Data’ under the Data Protection Directive. Eur J Health Law 11: 231–244.
Gevers, S. (2005) Human Tissue Research, with Particular Reference to DNA Biobanking. In: Gevers, J.K.M., Hondius, E.H. & Hubben, J.H. (eds.) Health Law, Human Rights and the Biomedicine Convention, Martinus Nijhoff Publishers, Boston, MA, pp. 231–243.
Greely, H.T. (2007) The Uneasy Ethical and Legal Underpinnings of Large-Scale Genomic Biobanks. Annu Rev Genomics Hum Genet 8: 343–364.
Halvorsen, M. (2006) Norsk biobankrett – Rettslig regulering av humant biologisk materiale, Fagbokforlaget, Bergen.
Harmon, S.H.E. (2006) The Recommendation on Research on Biological Materials of Human Origin: Another Brick in the Wall, Eur J Health Law 13: 293–310.
Hartlev, M. (2005) Fortrolighed i sundhedsretten – et patientretligt perspektiv, Forlaget Thomson A/S, Copenhagen.
Helgasson, H.H. (2004) Informed Consent for Donating Biosamples in Medical Research – Legal Requirements in Iceland. In: ´Arnason et al. (eds.) Blood and Data. Ethical, Legal and Social Aspects of Human Genetic Databases, University of Iceland Press & Center for Ethics, Reykjavik, pp. 127–134.
Hermerén, G. (1997) Protecting Human Integrity. In: Sorsa, M. & Eyrfjörö, J. (eds.), Human biobanks – Ethical and Social Issues (Nord 1997:9), The Nordic Committee on Bioethics, Copenhagen, pp. 17–36.
Hervey, T.K. & McHale, J.V. (2004) Health Law and the European Union, Cambridge University Press, Cambridge.
Hondius, F.W. (1997) Protecting Medical and Genetic Data, European J Health Law 4: 361–388.
Kakuk, P. (2008) Gene Concepts and Genethics: Beyond Exceptionalism, Sci Eng Ethics 14(3): 357–375.
Kaye, J. (2006) Do We Need a Uniform Regulatory System for Biobanks Across Europe? Eur J Hum Genet 14: 245–248.
Knoppers, B.M. & Laberge, C. (1989), DNA Sampling and Informed Consent, CMAJ, 140: 1023–1028.
Knoppers B.M. & Fecteau, C. (2003), Human Genomic Databases: A Global Public Good? Eur J Health Law 10: 27–41.
Laurie, G. (2002) Genetic Privacy – A Challenge to Medico-Legal Norms, Cambridge University Press, Cambridge.
Legislation on Biotechnology in the Nordic Countries – An overview, TemaNord 2006:506, www.norden.org/pub/ovrigt/ovrigt/uk/TN2006506.pdf.
McNally, E. & Cambon-Thomsen, A. et al. (2004a) 25 Recommendations on the Ethical, Legal and Social Implications of Genetic Testing, European Commission, Brussels.
McNally, E. & Cambon-Thomsen, A. et al. (2004b) Ethical, Legal and Social Aspects of Genetic Testing: Research, Development and Clinical Applications, European Commission, Brussels.
Milunsky, A & Annas G.J. (eds.) (1976) Genetics and the Law, Plenum Press, New York.
Murray, T.H. (1997) Genetic Exceptionalism and ‘Future Diaries’: Is Genetic Information Different from Other Medical Information? In Rothstein, M.A. (ed.), Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. Yale University Press, New Haven.
Mörth, U. (2004a) Introduction; Conlusions. In: Mörth, U. (ed.) Soft Law in Governance and Regulation: An Interdisciplinary Analysis, E. Elgar Publisher, Northampton, MA.
Nelkin, D. & Andrews, L. (1998) Homo Economicus Commercialization of Body Tissue in the Age of Biotechnology, The Hastings Center Report, Vol. 28, No. 5, pp. 30–39.
Nielsen, L. et al. (1996) Health Science Information Banks: Biobanks: Danish Central Scientific- Ethical Committee, Danish Council of Ethics, Danish Medical Research Council, Copenhagen.
Nys, H. (2008) Research on Human Biological Materials and the Council of Europe: Some Unanswered Questions, Overlaps and Empty Boxes. European Journal of Health Law 15: 1–6.
Ossorio, P.N. (2007) The Human Genome as Common Heritage: Common Sense or Legal Nonsense? J Law, Med Ethics 35: 425–437.
Riis, P. (1997) Biobanks Yesterday, Today and Tomorrow:Purposes, Types and Controversies. Human Biobanks – Ethical and Social Issues. In: Sorsa, M. & Eyrfjörö, J. (eds.), Human Biobanks – Ethical and Social Issues (Nord 1997:9), The Nordic Committee on Bioethics, Copenhagen, pp. 37–41.
Romeo Casabona, C.M. (2004) Anonymization and Pseudonymization: Legal Framework at a European Level. In: Beyleveld, D., Townend, D., Rouillé-Mirza, S. &Wright, J. (eds.) The Data Protection Directive and Medical Research Across Europe, Ashgate Publishing, Aldershot, pp. 34–49.
Roucounas, E. (2005) The Biomedicine Convention in Relation to Other International Instruments. In: Gevers, J.K.M., Hondius, E.H. & Hubben, J.H. (eds.) Health Law, Human Rights and the Biomedicine Convention, Martinus Nijhoff Publishers, Boston, MA.
Rouillé-Mirza, S. & Wright, J. Comparative Study on the Implementation and Effect of Directive 95/46/EC on Data Protection in Europe: Medical Research. In: Beyleveld, D. et al. (eds.) The Data Protection Directive and Medical Research Across Europe, Ashgate Publishing, Aldershot, pp. 189–230.
Rynning, E. (2003a), Public Law Aspects on the Use of Biobank Samples – Privacy Versus the Interests of Research. In: Hansson, M. & Levin, M. (eds.) Biobanks as Resources for Health, Research Program Ethics in Biomedicine, Uppsala University, Uppsala, pp. 91–128.
Rynning, E. (2003b) Offentligrä ttslig reglering av biobankerna – en utmaning för lagstiftaren. In: Wolk, S. (ed.), Biobanksrä tt, Studentlitteratur, Lund, pp. 49–175.
Rynning, E. (2004) Processing of Personal Data in Swedish Health Care and Biomedical Research. In: Beyleveld, D. et al. (eds.) Implementation of the Data Protection Directive in Relation to Medical Research in Europe Aldershot: Ashgate Publishing, Aldershot, pp. 381–402.
Rynning, E. (2009) Legal Tools and Strategies for the Regulation of Chimbrids. Taupitz, J. & Weschka, M. (eds.), CHIMBRIDS – Chimeras and Hybrids in Comparative European and International Research, Springer, Berlin, pp. 80–88.
Senden, L. (2005) Soft Law, Self-Regulation and Co-regulation in European law: Where Do They Meet? Electron J Comp Law, 9.1: 23.
Sethe, S. (2004) Cell Line Research with UK Biobank – Why the New British Biobank Is Not Just Another Population Genetic Database. In: ´Arnason, G. et al. (eds.). Blood and Data – Ethical, Legal and Social Aspects of Human Genetic Databases, University of Iceland Press & Center for Ethics, Reykjavik, pp. 313–319.
Sheremeta, L. & Knoppers, B.M. (2007) Beyond the Rhetoric: Population Genetics and Benefit- Sharing. In: Phillips, P.W.B. & Onwuekwe, C.B. (eds.). Accessing and Sharing the Benefits of the Genomics Revolution, Springer, Berlin, pp. 157–182.
Wendel, L. (2007) Third Parties’ Interests in Population Genetic Databases: Some Comparative Notes Regarding the Law in Estonia, Iceland, Sweden and the UK. In: Häyry, M. et al. (eds.) The Ethics and Governance of Human Genetic Databases – European Perspectives, Cambridge University Press, Cambridge, pp. 108–119.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Rynning, E. (2009). Legal Challenges and Strategies in the Regulation of Research Biobanking. In: Solbakk, J., Holm, S., Hofmann, B. (eds) The Ethics of Research Biobanking. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-93872-1_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-93872-1_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-93871-4
Online ISBN: 978-0-387-93872-1
eBook Packages: MedicineMedicine (R0)